PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
Data generation and assessment | ARN | Regulatory risk management | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sodium N-lauroylsarcosinate | 205-281-5 | 137-16-6 | - | - | 5 | - | 1 | - | - | - | - | Details |
Sodium N-chlorobenzenesulphonamide | 204-847-9 | 127-52-6 | - | - | 1 | - | - | - | - | - | - | Details |
Sodium N-(hydroxymethyl)glycinate | 274-357-8 | 70161-44-3 | - | - | - | - | - | 1 | - | - | - | Details |
Sodium N-(2-carboxyethyl)-N-dodecyl-β-alaninate | 239-032-7 | 14960-06-6 | - | - | 1 | - | 1 | - | - | - | - | Details |
Sodium N-(2-carboxyethyl)-N-(2-ethylhexyl)-β-alaninate | 305-318-6 | 94441-92-6 | - | - | 5 | - | 1 | - | - | - | - | Details |
Sodium N,N-bis(2-hydroxyethyl)glycinate | 205-360-4 | 139-41-3 | - | - | - | - | 1 | - | - | - | - | Details |
Sodium methylsilanetriolate | 240-648-3 | 16589-43-8 | - | - | - | - | 1 | - | - | - | - | Details |
Sodium methyl sulphate | 208-142-7 | 512-42-5 | - | - | - | - | 1 | - | - | - | - | Details |
sodium methyl [(4-aminophenyl)sulphonyl]carbamate; asulam-sodium | 218-953-8 | 2302-17-2 | - | - | - | - | - | 1 | - | - | - | Details |
Sodium methyl 2-sulphooctadecanoate | 223-770-1 | 4062-78-6 | - | - | - | - | 1 | - | - | - | - | Details |
Sodium methanolate | 204-699-5 | 124-41-4 | - | - | 4 | - | - | - | - | - | - | Details |
Sodium methanethiolate | 225-969-9 | 5188-07-8 | - | - | 1 | - | - | - | - | - | - | Details |
Sodium methanesulphonate | 219-203-2 | 2386-57-4 | - | - | - | - | 1 | - | - | - | - | Details |
Sodium metavanadate | 237-272-7 | 13718-26-8 | - | - | 1 | - | 1 | - | - | - | - | Details |
Sodium metaborate, anhydrous | 231-891-6 | 7775-19-1 | - | - | - | - | - | 2 | - | - | - | Details |
Sodium mercaptoacetate | 206-696-4 | 367-51-1 | - | - | 1 | - | - | - | - | - | - | Details |
Sodium mentholate | 242-958-4 | 19321-38-1 | - | - | - | - | 1 | - | - | - | - | Details |
Sodium lauroyl oat aminoacids | 686-761-5 | 222400-43-3 | - | - | - | - | 1 | - | - | - | - | Details |
Sodium iodide | 231-679-3 | 7681-82-5 | - | - | 2 | - | - | - | - | - | - | Details |
Sodium icosyl sulphate | 236-125-4 | 13177-49-6 | - | - | - | - | 1 | - | - | - | - | Details |
Sodium hypochlorite | 231-668-3 | 7681-52-9 | - | - | - | - | - | 1 | - | - | - | Details |
Sodium hydroxymethanesulphinate | 205-739-4 | 149-44-0 | 1 | - | 5 | - | - | - | - | - | - | Details |
Sodium hydroxide | 215-185-5 | 1310-73-2 | - | - | - | - | 1 | - | - | - | - | Details |
Sodium hydrogensulphate | 231-665-7 | 7681-38-1 | - | - | 1 | - | - | - | - | - | - | Details |
Sodium hydrogensulfite | 231-548-0 | 7631-90-5 | - | - | 1 | - | - | - | - | - | - | Details |